Likarda
Description
pulled from site's meta descriptionExciting biotech company bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people.
Domain Resolution
This domain resolves to the following IP addresses:This is an automatically generated AboutUs page for Likarda.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Karthik Ramachandran
- Lisa Stehno-Bittel
- Animal Health
- Bioengineering
- Kanslets
- Canine diabetes
- Companion animals
- Micromolds
- Animal pharm
- Bio
- Biotech
- Kansas city animal health
- Likarda
- Likarda bio
- Likarda animal health
- Diabetes dog
- Diabetes cat
- Diabetes cure
- Diabetes dogs
- Diabetes cats
- Diabetes pet
- Diabetes pets
- Disruptive
- A new dimension in healing pets and people
- Three-dimensional
- 3D
- 3D research
- 3D cells
- 3D science
- Miniature organs
- Miniaturized
- organs
- Drug discover
- Drug development
- Cell-based therapies
- Cell-based
- Cell-based transplantation
- Pancreas transplant
- Regenerative medicine
- Regenerative science
- Reaggregated cells
- Next generation treatments
- Diabetes treatment
- Diabetes transplant
- Micromold plate
- Micromold plates
- Plate technology
- Islet cells
- Islet cell transplant
- Reaggregated islet
- Veterinarian diabetes
- Veterinarian technology
- Kansas animal health
- Kansas science
- Kansas bioengineering
- Disruptive technologies
- Cell culture
- Cell culture system
- Translational medicine
- One health
- Healthcare innovation
- Veterinary innovation
- Transplantation kit
- Engineered cells
- Engineered islets
- Engineered islet cells
- Diabetic dog
- Diabetic cat
- Diabetic dogs
- Diabetic cats
- Dog diabetes treatment
- Cat diabetes treatment
- Animal health corridor
- Consultative research
- Analytical services
- 3D screening
- Pharmaceutical research
- Assaying technology
- Microplates
- Micro plates
- Micro plate
- 3D cluster technology
- Life sciences
- Kansas city life sciences
- Insulin-producing cells
- Animal regenerative medicine
- Contract research organization
- Cell engineering
- Multi-cell
- organotypic 3D cell clusters
- screening diabetes drugs